- Record: found
- Abstract: found
- Article: not found
Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
June-Won Cheong
1 ,
Hyeoung-Joon Kim ,
Kyoo-Hyung Lee ,
Sung-Soo Yoon ,
Jae Hoon Lee ,
Hee-Sook Park ,
Ho Young Kim ,
Hyeok Shim ,
Chu-Myung Seong ,
Chul Soo Kim ,
Jooseop Chung ,
Myung Soo Hyun ,
Deog-Yeon Jo ,
Chul Won Jung ,
Sang Kyun Sohn ,
Hwi-Joong Yoon ,
Byung Soo Kim ,
Young-Don Joo ,
Chi-Young Park ,
Yoo Hong Min
Jun 2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Transfusional iron overload and its consequences are challenges in chronically transfused patients with myelodysplastic syndromes (MDSs) or aplastic anemia (AA).